Model predictions assuming 60% chronic HCV prevalence and 30% or 50% of the people who inject drugs sharing injection equipment.

We assumed that no treatment is provided after 2030.Mean time of HCV acquisition greater than 25 years is shown as 24+ years. Mean time corresponds to Tx only scenario. Tx: Antiviral treatment, HR: harm reduction, Counselling: Psychological interventions to reduce re-infections post- treatment. A. 30% sharers-Prevalence B. 30% sharers-HCV Incident cases C. 50% sharers-Prevalence D. 50% sharers-HCV Incident cases.